Evolutionary Mechanisms of the Emergence of the Variants of Concern of SARS-CoV-2

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2025 Feb 26

PMID 40006952

Authors

Igor M Rouzine

Affiliations

Soon will be listed here.

Abstract

The evolutionary origin of the variants of concern (VOCs) of SARS-CoV-2, characterized by a large number of new substitutions and strong changes in virulence and transmission rate, is intensely debated. The leading explanation in the literature is a chronic infection in immunocompromised individuals, where the virus evolves before returning into the main population. The present article reviews less-investigated hypotheses of VOC emergence with transmission between acutely infected hosts, with a focus on the mathematical models of stochastic evolution that have proved to be useful for other viruses, such as HIV and influenza virus. The central message is that understanding the acting factors of VOC evolution requires the framework of stochastic multi-locus evolution models, and that alternative hypotheses can be effectively verified by fitting results of computer simulation to empirical data.

References

Batorsky R, Kearney M, Palmer S, Maldarelli F, Rouzine I, Coffin J . Estimate of effective recombination rate and average selection coefficient for HIV in chronic infection. Proc Natl Acad Sci U S A. 2011; 108(14):5661-6. PMC: 3078368. DOI: 10.1073/pnas.1102036108. View

Liu D, Zuo T, Hora B, Song H, Kong W, Yu X . Preexisting compensatory amino acids compromise fitness costs of a HIV-1 T cell escape mutation. Retrovirology. 2014; 11:101. PMC: 4264250. DOI: 10.1186/s12977-014-0101-0. View

Moulana A, Dupic T, Phillips A, Chang J, Nieves S, Roffler A . Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1. Nat Commun. 2022; 13(1):7011. PMC: 9668218. DOI: 10.1038/s41467-022-34506-z. View

Goonetilleke N, Liu M, Salazar-Gonzalez J, Ferrari G, Giorgi E, Ganusov V . The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med. 2009; 206(6):1253-72. PMC: 2715063. DOI: 10.1084/jem.20090365. View

Carabelli A, Peacock T, Thorne L, Harvey W, Hughes J, Peacock S . SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol. 2023; 21(3):162-177. PMC: 9847462. DOI: 10.1038/s41579-022-00841-7. View

Batorsky R, Sergeev R, Rouzine I . The route of HIV escape from immune response targeting multiple sites is determined by the cost-benefit tradeoff of escape mutations. PLoS Comput Biol. 2014; 10(10):e1003878. PMC: 4214571. DOI: 10.1371/journal.pcbi.1003878. View

Smith C, Ashby B . Antigenic evolution of SARS-CoV-2 in immunocompromised hosts. Evol Med Public Health. 2023; 11(1):90-100. PMC: 10061940. DOI: 10.1093/emph/eoac037. View

Neher R, Russell C, Shraiman B . Predicting evolution from the shape of genealogical trees. Elife. 2014; 3. PMC: 4227306. DOI: 10.7554/eLife.03568. View

Ganusov V, De Boer R . Estimating Costs and Benefits of CTL Escape Mutations in SIV/HIV Infection. PLoS Comput Biol. 2006; 2(3):e24. PMC: 1420660. DOI: 10.1371/journal.pcbi.0020024. View

10.

Tay J, Porter A, Wirth W, Duchene S . The Emergence of SARS-CoV-2 Variants of Concern Is Driven by Acceleration of the Substitution Rate. Mol Biol Evol. 2022; 39(2). PMC: 8807201. DOI: 10.1093/molbev/msac013. View

11.

Althaus C, De Boer R . Dynamics of immune escape during HIV/SIV infection. PLoS Comput Biol. 2008; 4(7):e1000103. PMC: 2423483. DOI: 10.1371/journal.pcbi.1000103. View

12.

Thorne L, Bouhaddou M, Reuschl A, Zuliani-Alvarez L, Polacco B, Pelin A . Evolution of enhanced innate immune evasion by SARS-CoV-2. Nature. 2021; 602(7897):487-495. PMC: 8850198. DOI: 10.1038/s41586-021-04352-y. View

13.

Otto S, Day T, Arino J, Colijn C, Dushoff J, Li M . The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Curr Biol. 2021; 31(14):R918-R929. PMC: 8220957. DOI: 10.1016/j.cub.2021.06.049. View

14.

Yi H . 2019 Novel Coronavirus Is Undergoing Active Recombination. Clin Infect Dis. 2020; 71(15):884-887. PMC: 7108124. DOI: 10.1093/cid/ciaa219. View

15.

Rast L, Rouzine I, Rozhnova G, Bishop L, Weinberger A, Weinberger L . Conflicting Selection Pressures Will Constrain Viral Escape from Interfering Particles: Principles for Designing Resistance-Proof Antivirals. PLoS Comput Biol. 2016; 12(5):e1004799. PMC: 4859541. DOI: 10.1371/journal.pcbi.1004799. View

16.

Jackson B, Boni M, Bull M, Colleran A, Colquhoun R, Darby A . Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic. Cell. 2021; 184(20):5179-5188.e8. PMC: 8367733. DOI: 10.1016/j.cell.2021.08.014. View

17.

Rouzine I, Coffin J . Search for the mechanism of genetic variation in the pro gene of human immunodeficiency virus. J Virol. 1999; 73(10):8167-78. PMC: 112834. DOI: 10.1128/JVI.73.10.8167-8178.1999. View

18.

Zhang T, Dai L, Barton J, Du Y, Tan Y, Pang W . Predominance of positive epistasis among drug resistance-associated mutations in HIV-1 protease. PLoS Genet. 2020; 16(10):e1009009. PMC: 7605711. DOI: 10.1371/journal.pgen.1009009. View

19.

Fun A, Wensing A, Verheyen J, Nijhuis M . Human Immunodeficiency Virus Gag and protease: partners in resistance. Retrovirology. 2012; 9:63. PMC: 3422997. DOI: 10.1186/1742-4690-9-63. View

20.

Harari S, Tahor M, Rutsinsky N, Meijer S, Miller D, Henig O . Drivers of adaptive evolution during chronic SARS-CoV-2 infections. Nat Med. 2022; 28(7):1501-1508. PMC: 9307477. DOI: 10.1038/s41591-022-01882-4. View